Delivery Order SPE2DB22D1103-SPE2DB25FTSN1
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,331.75 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency has awarded a delivery order valued at $6,443.44 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of July 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,105.21 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a leading pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a delivery order valued at $7,090.56 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. The contract represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025, and was awarded on August 25, 2025. This award was competitively awarded with no set-aside designation. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $7,078.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% Patch, with an ultimate completion date of September 17, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $8,713.89 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of June 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,041.56 to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30-count units. Issued on July 21, 2025, with completion scheduled for July 22, 2025, this firm fixed-price contract represents a small-value pharmaceutical supply order to support federal medical procurement needs. The award utilizes no set-aside designation and reflects competitive procurement practices. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $4,228.36 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of September 9, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and operates as the child contractor under the company's larger indefinite delivery...
- The Defense Logistics Agency awarded a $7,248.31 delivery order to AmerisourceBergen Drug Corp for Lidocaine 5% Patch 30s, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch 30-count units under a firm fixed-price contract with a ceiling value of $4,246.98. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FTSN1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,906.40 to AmerisourceBergen Drug Corp for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price contract, effective July 22-23, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively procured through open competition. This delivery order supports the Defense Health Agency and military healthcare programs by providing lidocaine patches, a topical anesthetic commonly used for localized pain management in clinical and field settings. AmerisourceBergen's role as a pharmaceutical prime vendor under the DLA Troop Support Medical contract enables the company to fulfill critical medical supply needs across the federal healthcare system. The award reflects the company's established capability to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 7/22/25 |